Stock Report

All about this stock under one free report Last Updated: 03-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Cyclo Therapeutics (CYTH) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.72

$0.00 (0.00%)

As on 27-Mar-2025 09:30EDT

Market cap

info icon

$24 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

59.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 89.90 -52.82 -8.52 -8.76 -3.10
EBIT -47.03 -73.88 -27.54 -36.45 -214.27
Net Profit -47.68 -85.12 -28.99 -36.98 -214.40
EPS -47.21 -4.33 45.70 17.70 13.21
Book Value -- -- -13.44 -59.16 -26.52
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-24Dec-23Dec-22
EBIT-Margin info -1,620.29-1,350.76-1,862.69-1,862.69-1,135.51
Net Margin info ----------
Return on equity info -446.13-320.92-421.64-730.48-186.27
Return on Capital info -381.86-281.39-346.41-614.81-184.35
Return on Assets info -169.96-138.45-151.40-229.72-128.75
Debt to Equity (x) info ----0.220.22--

Profitability

View Detailed Peer Comparison

ROCE

-346.41

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
-346.41
-614.81
-184.35
-108.01
-153.38
Peer Median
--
--
--
--
--
ROE

-421.64

--

Profit after tax / Average Net worth * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
-421.64
-730.48
-186.27
-109.52
-156.70
Peer Median
--
--
--
--
--
ROA

-151.40

--

Profit after tax / Average Total assets * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
-151.40
-229.72
-128.75
-84.88
-97.51
Peer Median
--
--
--
--
--
EBIT Margin

-1,862.69

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
-1,862.69
-1,862.69
-1,135.51
-900.94
-991.99
Peer Median
--
--
--
--
--
Net Margin

-1,863.36

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
-1,863.36
-1,863.36
-1,110.65
-902.10
-987.75
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
--
-0.22
-0.13
0.76
-0.10
Peer Median
--
--
--
--
--
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
--
-28.35
-9.35
-59.42
-21.25
Peer Median
--
--
--
--
--
Net Profit Growth

--

--

Year on year growth in profit after tax

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
--
-31.27
-6.81
-60.32
-16.27
Peer Median
--
--
--
--
--
EPS Growth

0.13

--

Year on year growth in earnings per share

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
0.13
0.55
0.19
-0.33
0.74
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.22

--

Total debt / Net worth

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
0.22
0.22
--
0.01
0.02
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.21

--

(Short term borrowings / Net worth)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
0.21
0.42
--
0.01
0.01
Peer Median
--
--
--
--
--
Current Ratio

1.45

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
1.45
1.45
1.19
5.07
3.83
Peer Median
--
--
--
--
--
Quick Ratio

1.42

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
1.42
1.42
1.12
5.01
3.76
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
--
--
-103.83
-771.33
--
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

11.37

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
11.37
11.37
4.00
34.00
12.37
Peer Median
--
--
--
--
--
Asset Turnover

0.08

--

Sales / Average Total Assets

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
0.08
0.12
0.12
0.09
0.10
Peer Median
--
--
--
--
--
Receivable days

41.53

--

Average Debtors / Sales * 365

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
41.53
30.09
78.86
74.96
59.49
Peer Median
--
--
--
--
--
Inventory Days

943.57

--

Average Inventory / Sales * 365

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
943.57
26.65
633.50
544.49
1,321.70
Peer Median
--
--
--
--
--
Payable days

18,016.29

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
18,016.29
371.39
7,771.28
8,446.78
18,333.95
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-17,031.19

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
-17,031.19
-314.65
-7,058.91
-7,827.33
-16,952.75
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-0.85

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
-0.85
-1.97
-0.79
-1.68
-2.60
Peer Median
--
--
--
--
--
Price / Book Value

3.56

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
3.56
8.31
16.36
1.53
2.22
Peer Median
--
--
--
--
--
EV/EBITDA

-0.44

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Cyclo Therapeutics (CYTH)
-0.44
-1.56
-0.67
-0.53
-1.18
Peer Median
--
--
--
--
--
loading...
loading...